tradingkey.logo
๎™
๎™ผ
tradingkey.logo
๎™

Sanofi SA

SNY
46.620USD
+0.590+1.28%
์ข…๊ฐ€ย 03/26, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
112.59B์‹œ๊ฐ€์ด์•ก
12.92P/E TTM
๎™

Sanofi SA

46.620
+0.590+1.28%
TradingKey ์ฃผ์‹ ์ ์ˆ˜
๊ฑด๊ฐ•
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
์œ ์‚ฌ ์ข…๋ชฉ
TradingKey ์ฃผ์‹ ์ ์ˆ˜
๊ฑด๊ฐ•
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
์œ ์‚ฌ ์ข…๋ชฉ

TradingKey Sanofi SA ์ฃผ์‹ ์ ์ˆ˜

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-03-25

์ฃผ์š” ์ธ์‚ฌ์ดํŠธ

Sanofi SA์˜ ํŽ€๋”๋ฉ˜ํ„ธ์€ ๋น„๊ต์  ๊ฑด์ „ํ•œ ์ƒํƒœ์ด๋ฉฐ, ESG ๊ณต์‹œ๋Š” ์—…๊ณ„๋ฅผ ์„ ๋„ํ•˜๋Š” ์ˆ˜์ค€์ž…๋‹ˆ๋‹ค.์„ฑ์žฅ ์ž ์žฌ๋ ฅ์€ ๋†’์Šต๋‹ˆ๋‹ค.๊ธฐ์—…์˜ ๋ฐธ๋ฅ˜์—์ด์…˜์€ ์ ์ •ํ•˜๊ฒŒ ํ‰๊ฐ€๋œ ๊ฒƒ์œผ๋กœ ๊ฐ„์ฃผ๋˜๋ฉฐ, ์ œ์•ฝ ์‚ฐ์—…์—์„œ 157๊ฐœ ์ค‘ 61์œ„ ๋žญํ‚น.๊ธฐ๊ด€ ๋ณด์œ  ๋น„์œจ์€ ๋งค์šฐ ๋†’์€.์ง€๋‚œ ํ•œ ๋‹ฌ ๋™์•ˆ ์—ฌ๋Ÿฌ ์• ๋„๋ฆฌ์ŠคํŠธ๊ฐ€ ํ•ด๋‹น ๊ธฐ์—…์„ ๋งค์ˆ˜(์œผ)๋กœ ํ‰๊ฐ€ํ–ˆ์œผ๋ฉฐ, ์ตœ๊ณ  ๋ชฉํ‘œ ๊ฐ€๊ฒฉ์€ 59.19์ž…๋‹ˆ๋‹ค.์ค‘๊ธฐ์ ์œผ๋กœ ์ฃผ๊ฐ€๋Š” ์•ˆ์ •์ ์ธ ์ƒํƒœ๋ฅผ ์œ ์ง€ํ•  ๊ฒƒ์œผ๋กœ ์˜ˆ์ƒ๋ฉ๋‹ˆ๋‹ค.์ง€๋‚œ ํ•œ ๋‹ฌ๊ฐ„ ์ฃผ์‹ ์‹œ์žฅ์—์„œ ํ‰๋ฒ”ํ•œ ์„ฑ๊ณผ๋ฅผ ๊ฑฐ๋‘์—ˆ์ง€๋งŒ, ๊ธฐ์—…์˜ ํŽ€๋”๋ฉ˜ํ„ธ๊ณผ ๊ธฐ์ˆ ์  ์ง€ํ‘œ๋Š” ํƒ„ํƒ„ํ•ฉ๋‹ˆ๋‹ค.์ฃผ๊ฐ€๋Š” ์ง€์ง€์„ ๊ณผ ์ €ํ•ญ์„  ์‚ฌ์ด์—์„œ ํšก๋ณดํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ๋ฒ”์œ„ ๋งค๋งค ๊ธฐ๋ฐ˜์˜ ์Šค์œ™ ํŠธ๋ ˆ์ด๋”ฉ์— ์ ํ•ฉํ•œ ์ƒํ™ฉ์ž…๋‹ˆ๋‹ค.

Sanofi SA ์ ์ˆ˜๎˜ฐ๎˜ฐ

๊ด€๋ จ ์ •๋ณด

์‚ฐ์—… ์ˆœ์œ„
61 / 157
์ „์ฒด ์ˆœ์œ„
170 / 4547
์‚ฐ์—…
์ œ์•ฝ

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

๋ ˆ์ด๋” ์ฐจํŠธ

ํ˜„์žฌ ๊ฐ€๊ฒฉ
๊ณผ๊ฑฐ

๋ฏธ๋””์–ด ๋ณด๋„

์ตœ๊ทผ 24 ์‹œ๊ฐ„
๋ณด๋„ ์ˆ˜์ค€

๋งค์šฐ ๋‚ฎ์€
๋งค์šฐ ๋†’์€
์ค‘๋ฆฝ

Sanofi SA ์ฃผ์š” ๋‚ด์šฉ

๊ฐ•์ ์œ„ํ—˜ ์š”์†Œ
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofiโ€™s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Companyโ€™s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
๋†’์€ ์„ฑ์žฅ
ํšŒ์‚ฌ์˜ ๋งค์ถœ์€ ์ง€๋‚œ 3๋…„๊ฐ„ ๊พธ์ค€ํžˆ ์„ฑ์žฅํ•ด์™”์œผ๋ฉฐ, ์—ฐํ‰๊ท  17.07%์˜ ์ฆ๊ฐ€์œจ์„ ๊ธฐ๋กํ–ˆ์Šต๋‹ˆ๋‹ค.
๊ณ ์ˆ˜์ต ์„ฑ์žฅ
ํšŒ์‚ฌ์˜ ์ˆœ์ด์ต์€ ์—…๊ณ„ ์„ ๋‘๋ฅผ ๋‹ฌ๋ฆฌ๊ณ  ์žˆ์œผ๋ฉฐ, ์ตœ๊ทผ ์—ฐ๊ฐ„ ์ˆœ์ด์ต์€ ๋ฏธํ™” 52.67B์— ๋‹ฌํ•ฉ๋‹ˆ๋‹ค.
๋†’์€ ๋ฐฐ๋‹น๊ธˆ
ํšŒ์‚ฌ๋Š” ๋†’์€ ๋ฐฐ๋‹น๊ธˆ์„ ์ง€๊ธ‰ํ•˜๋Š” ํšŒ์‚ฌ๋กœ, ์ตœ์‹  ๋ฐฐ๋‹น๊ธˆ ์ง€๊ธ‰ ๋น„์œจ์€ 171.67%์ž…๋‹ˆ๋‹ค.
์•ˆ์ •์ ์ธ ๋ฐฐ๋‹น๊ธˆ
ํšŒ์‚ฌ๋Š” ์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ •๊ธฐ์ ์œผ๋กœ ๋ฐฐ๋‹น๊ธˆ์„ ์ง€๊ธ‰ํ•˜์˜€์œผ๋ฉฐ, ์ตœ์‹  ๋ฐฐ๋‹น๊ธˆ ์ง€๊ธ‰ ๋น„์œจ์€ 171.67%์ž…๋‹ˆ๋‹ค.
๊ณผ์†Œ ํ‰๊ฐ€๋œ
ํšŒ์‚ฌ์˜ ์ตœ์‹  PE์€ 12.75๋กœ, ์ตœ๊ทผ 3๋…„ ๊ธฐ์ค€ ๋‚ฎ์€ ๋ฐฑ๋ถ„์œ„ ๋ฒ”์œ„์— ์†ํ•ฉ๋‹ˆ๋‹ค.
๊ธฐ๊ด€ ๋งค๋„
์ตœ์‹  ๊ธฐ๊ด€ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋Š” 242.88M์ฃผ์ด๋ฉฐ, ์ „ ๋ถ„๊ธฐ ๋Œ€๋น„ 9.36% ๊ฐ์†Œํ–ˆ์Šต๋‹ˆ๋‹ค.
CI Select Canadian Equity Fund๊ฐ€ ๋ณด์œ 
์Šคํƒ€ ํˆฌ์ž์ž CI Select Canadian Equity Fund์ด(๊ฐ€) ์ด ์ฃผ์‹ 34.20K์ฃผ๋ฅผ ๋ณด์œ ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

๋ถ„์„๊ฐ€ ๋ชฉํ‘œ๊ฐ€

10 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
๋งค์ˆ˜
ํ˜„์žฌ ๋“ฑ๊ธ‰
59.185
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
+32.20%
์ƒ์Šน ์—ฌ๋ ฅ
๋ฉด์ฑ… ์กฐํ•ญ: ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€ ๋ฐ ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” ์ •๋ณด ์ œ๊ณต์„ ์œ„ํ•œ ๋ชฉ์ ์œผ๋กœ LSEG์—์„œ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

์žฌ๋ฌด ๊ฑด์ „์„ฑ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-03-25

Sanofi SA์˜ ํ˜„์žฌ ์žฌ๋ฌด ์ ์ˆ˜๋Š” 7.35์ ์ด๋ฉฐ, ์ œ์•ฝ ์‚ฐ์—… ๋‚ด ์ด 157๊ฐœ ๊ธฐ์—… ์ค‘ 112์œ„์ž…๋‹ˆ๋‹ค. ๊ธฐ์—…์˜ ์žฌ๋ฌด ์ƒํƒœ๋Š” ์•ˆ์ •์ ์ธ ์ƒํƒœ์ด๋ฉฐ, ๊ธฐ์—…์˜ ์šด์˜ ํšจ์œจ์„ฑ์€ ์ƒ๋‹จ์ž…๋‹ˆ๋‹ค. ๊ธฐ์—…์˜ ์ตœ๊ทผ ๋ถ„๊ธฐ ๋งค์ถœ์€ 14.21B์ด๋ฉฐ, ์ด๋Š” ์ „๋…„ 74.57% ๋Œ€๋น„ ์ฆ๊ฐ€์— ํ•ด๋‹นํ•ฉ๋‹ˆ๋‹ค. ํ•œํŽธ, ์ˆœ์ด์ต์€ ์ „๋…„ 275.21% ๋Œ€๋น„ ์ฆ๊ฐ€์„(๋ฅผ) ๊ธฐ๋กํ–ˆ์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
7.35
๋ณ€๊ฒฝ
0
๎™ธ

์žฌ๋ฌด ์ •๋ณด

๎˜ญ6.49

์ฃผ์š” ์ง€ํ‘œ

ํ˜„๊ธˆ ๋ฐ ํ˜„๊ธˆ์„ฑ ์ž์‚ฐ
์ด ์ž์‚ฐ
๋ถ€์ฑ„ ์ด๊ณ„
์ž์œ  ํ˜„๊ธˆ ํ๋ฆ„
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
๎™น

์ˆ˜์ต์˜ ์งˆ

๎˜ญ2.76
๎™น

์šด์˜ ํšจ์œจ์„ฑ

๎˜ญ10.00
๎™น

์„ฑ์žฅ ์ž ์žฌ๋ ฅ

๎˜ญ9.90
๎™น

์ฃผ์ฃผ ์ˆ˜์ต๋ฅ 

๎˜ญ7.59

Sanofi SA ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-03-25

Sanofi SA์˜ ํ˜„์žฌ ๊ฐ€์น˜ํ‰๊ฐ€ ์ ์ˆ˜๋Š” 5.82์ ์ด๋ฉฐ, ์ œ์•ฝ ์‚ฐ์—… ๋‚ด ์ด 157๊ฐœ ๊ธฐ์—… ์ค‘ 138์œ„์ž…๋‹ˆ๋‹ค. ํ˜„์žฌ ์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ(P/E)์€ 12.75์ด๋ฉฐ, ์ตœ๊ทผ ๊ณ ์  32.11 ๋Œ€๋น„ 151.79% ๋‚ฎ๊ณ , ์ตœ๊ทผ ์ €์  11.07 ๋Œ€๋น„ 13.23% ๋†’์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
5.82
๋ณ€๊ฒฝ
0

๋ฐธ๋ฅ˜์—์ด์…˜

์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ
P/B
์ฃผ๊ฐ€๋งค์ถœ๋น„์œจ
์ฃผ๊ฐ€ํ˜„๊ธˆํ๋ฆ„๋น„์œจ
์‚ฐ์—… ์ˆœ์œ„ 61/157
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์˜ˆ์ƒ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-03-25

Sanofi SA์˜ ํ˜„์žฌ ์ˆ˜์ต ์ „๋ง ์ ์ˆ˜๋Š” 8.00์ ์ด๋ฉฐ, ์ œ์•ฝ ์‚ฐ์—… ๋‚ด ๋žญํ‚น์€ 157๊ฐœ ์ค‘ 57์œ„์ž…๋‹ˆ๋‹ค. ํ‰๊ท  ๋ชฉํ‘œ๊ฐ€๋Š” 58.58์ด๋ฉฐ, ๊ณ ๊ฐ€๋Š” 74.67, ์ €๊ฐ€๋Š” 56.00์ž…๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
8.00
๋ณ€๊ฒฝ
0

๋ชฉํ‘œ๊ฐ€

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€

10 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
๋งค์ˆ˜
ํ˜„์žฌ ๋“ฑ๊ธ‰
59.185
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
+31.11%
์ƒ์Šน ์—ฌ๋ ฅ
๊ฐ•๋ ฅ ๋งค์ˆ˜
๋งค์ˆ˜
์œ ์ง€
๋งค๋„
๊ฐ•๋ ฅ ๋งค๋„

๋™์ข…์—…๊ณ„ ๋น„๊ต

174
์ด๊ณ„
6
์ค‘๊ฐ„
8
ํ‰๊ท 
ํšŒ์‚ฌ ์ด๋ฆ„
ํ‰๊ฐ€
๋ถ„์„๊ฐ€
Sanofi SA
SNY
10
Biogen Inc
BIIB
37
Amgen Inc
AMGN
36
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
33
Gilead Sciences Inc
GILD
32
1
2
3
...
35

์žฌ๋ฌด ์˜ˆ์ธก

EPS
์ˆ˜์ต
์ˆœ์ด์ต
EBIT
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

๋ฉด์ฑ… ์กฐํ•ญ: ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€ ๋ฐ ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” ์ •๋ณด ์ œ๊ณต์„ ์œ„ํ•œ ๋ชฉ์ ์œผ๋กœ LSEG์—์„œ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

๋ชจ๋ฉ˜ํ…€

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-03-25

Sanofi SA์˜ ํ˜„์žฌ ๊ฐ€๊ฒฉ ๋ชจ๋ฉ˜ํ…€ ์ ์ˆ˜๋Š” 7.23์ ์ด๋ฉฐ, ์ œ์•ฝ ์‚ฐ์—… ๋‚ด ๋žญํ‚น์€ 157๊ฐœ ์ค‘ 35์œ„์ž…๋‹ˆ๋‹ค. ํ˜„์žฌ ์ฃผ๊ฐ€๋Š” ์ €ํ•ญ์„  48.75๊ณผ ์ง€์ง€์„  43.32 ์‚ฌ์ด์—์„œ ๊ฑฐ๋ž˜๋˜๊ณ  ์žˆ์–ด, ํšก๋ณด ๊ตฌ๊ฐ„์„ ํ™œ์šฉํ•˜๋Š” ์Šค์œ™ ํŠธ๋ ˆ์ด๋”ฉ์— ์ ํ•ฉํ•œ ํ๋ฆ„์„ ๋ณด์ด๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
6.96
๋ณ€๊ฒฝ
0.27

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ง€ํ‘œ

๎˜ฐ
๎˜ฐ

์ง€ํ‘œ ๊ธฐ๋Šฅ์€ ๋‹ค์–‘ํ•œ ๊ธฐ๋ฒ• ์ง€ํ‘œ๋ฅผ ๊ธฐ๋ฐ˜์œผ๋กœ ์—ฌ๋Ÿฌ ์ข…๋ชฉ์— ๋Œ€ํ•œ ๊ฐ€์น˜์™€ ๋ฐฉํ–ฅ ๋ถ„์„์„ ์ œ๊ณตํ•˜๋ฉฐ, ๊ธฐ์ˆ ์  ์š”์•ฝ๋„ ํ•จ๊ป˜ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

์ด ๊ธฐ๋Šฅ์—๋Š” ์ผ๋ฐ˜์ ์œผ๋กœ ์‚ฌ์šฉ๋˜๋Š” 9๊ฐ€์ง€ ๊ธฐ์ˆ ์  ์ง€ํ‘œ๊ฐ€ ํฌํ•จ๋ฉ๋‹ˆ๋‹ค: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX, MA. ๋˜ํ•œ ํ•„์š”์— ๋”ฐ๋ผ ์‹œ๊ฐ„ ํ”„๋ ˆ์ž„์„ ์กฐ์ •ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๊ธฐ์ˆ  ๋ถ„์„์€ ํˆฌ์ž ์ฐธ์กฐ์˜ ์ผ๋ถ€์ผ ๋ฟ์ด๋ฉฐ, ๋ฐฉํ–ฅ์„ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•ด ์ˆซ์ž ๊ฐ’์„ ์‚ฌ์šฉํ•˜๋Š” ๋ฐ์—๋Š” ์ ˆ๋Œ€์ ์ธ ๊ธฐ์ค€์ด ์—†์Šต๋‹ˆ๋‹ค. ๊ฒฐ๊ณผ๋Š” ์ฐธ์กฐ์šฉ์ผ ๋ฟ์ด๋ฉฐ, ์ง€ํ‘œ ๊ณ„์‚ฐ ๋ฐ ์š”์•ฝ์˜ ์ •ํ™•์„ฑ์— ๋Œ€ํ•ด์„œ๋Š” ์ฑ…์ž„์ง€์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

์ง€ํ‘œ
๋งค๋„(1)
์ค‘๋ฆฝ(2)
๋งค์ˆ˜(1)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MACD(12,26,9)
0.617
์ค‘๋ฆฝ
RSI(14)
57.410
์ค‘๋ฆฝ
STOCH(KDJ)(9,3,3)
83.208
๋งค์ˆ˜
ATR(14)
0.890
์ €๋ณ€๋™์„ฑ
CCI(14)
200.003
๊ณผ๋งค๋„
Williams %R
13.836
๊ณผ๋งค๋„
TRIX(12,20)
-0.210
๋งค๋„
StochRSI(14)
100.000
๊ณผ๋งค๋„
์ด๋™ ํ‰๊ท 
๋งค๋„(2)
์ค‘๋ฆฝ(0)
๋งค์ˆ˜(4)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MA5
45.432
๋งค์ˆ˜
MA10
44.785
๋งค์ˆ˜
MA20
45.115
๋งค์ˆ˜
MA50
46.365
๋งค์ˆ˜
MA100
47.773
๋งค๋„
MA200
48.229
๋งค๋„

๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-03-25

Sanofi SA์˜ ํ˜„์žฌ ๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ  ์ ์ˆ˜๋Š” 3.00์ ์ด๋ฉฐ, ์ œ์•ฝ ์‚ฐ์—… ๋‚ด ๋žญํ‚น์€ 157๊ฐœ ์ค‘ 93์œ„์ž…๋‹ˆ๋‹ค. ์ตœ์‹  ๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ  ๋น„์œจ์€ 9.98%์ด๋ฉฐ, ์ด๋Š” ์ง€๋‚œ ๋ถ„๊ธฐ ๊ฐ์†Œ ๋Œ€๋น„ 3.38%์ž…๋‹ˆ๋‹ค. ์ตœ๋Œ€ ๊ธฐ๊ด€ ์ฃผ์ฃผ์ธ Van Duyn Dodge & E. Morris Cox์€(๋Š”) ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 2.34%์— ํ•ด๋‹นํ•˜๋Š” ์ด 56.49M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ๋ณด์œ  ์ง€๋ถ„์€ 19.26% ๊ฐ์†Œ์ž…๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
3.00
๋ณ€๊ฒฝ
0

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ฃผ์ฃผ ํ™œ๋™

์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
Chg %
68.93M
-3.89%
Fisher Investments
Star Investors๎˜ฏ
12.58M
-4.24%
Barrow Hanley Global Investors
Star Investors๎˜ฏ
7.13M
-2.11%
Managed Account Advisors LLC
6.44M
-13.90%
Invesco Advisers, Inc.
5.16M
-39.74%
Putnam Investment Management, L.L.C.
3.82M
-7.52%
Mondrian Investment Partners Ltd.
3.64M
+5.69%
Parametric Portfolio Associates LLC
3.48M
-5.74%
Morgan Stanley & Co. International Plc
2.61M
+231.10%
Boston Partners
3.68M
-7.82%
1
2

์œ„ํ—˜ ์š”์†Œ๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-03-25

ํ˜„์žฌ ๋ฏธ๊ตญ ๋‹ฌ๋Ÿฌ ์ง€์ˆ˜(DXY)๋Š” ์ค‘๋ฆฝ ์ƒํƒœ์— ์žˆ์œผ๋ฉฐ, ์ด๋Š” ์ œ์•ฝ ๋‚ด์ˆ˜ ์ค‘์‹ฌ ์‚ฐ์—…์— ์ค‘๋ฆฝ์  ์˜ํ–ฅ์„ ๋ฏธ์นฉ๋‹ˆ๋‹ค. ๋‹ฌ๋Ÿฌ ์ง€์ˆ˜(DXY)๋Š” ๋ฏธ๊ตญ ๋‹ฌ๋Ÿฌ์˜ ๊ฐ€์น˜๋ฅผ ์œ ๋กœ, ์—”ํ™”, ํŒŒ์šด๋“œ ์Šคํ„ธ๋ง, ์บ๋‚˜๋‹ค ๋‹ฌ๋Ÿฌ, ์Šค์›จ๋ด ํฌ๋กœ๋‚˜, ์Šค์œ„์Šค ํ”„๋ž‘ ๋“ฑ ์ฃผ์š” ํ†ตํ™” ๋ฐ”์Šค์ผ“๊ณผ ๋น„๊ตํ•ด ์ธก์ •ํ•ฉ๋‹ˆ๋‹ค. Sanofi SA์˜ ํ˜„์žฌ ๋ฆฌ์Šคํฌ ํ‰๊ฐ€ ์ ์ˆ˜๋Š” 9.65์ ์ด๋ฉฐ, ์ œ์•ฝ ์‚ฐ์—… ๋‚ด ๋žญํ‚น์€ 157๊ฐœ ์ค‘ 7์œ„์ž…๋‹ˆ๋‹ค. ๊ธฐ์—…์˜ ๋ฒ ํƒ€ ๊ฐ’์€ 0.43์ž…๋‹ˆ๋‹ค. ์ด๋Š” ํ•ด๋‹น ์ฃผ์‹์ด ์ƒ์Šน์žฅ์—์„œ๋Š” ์ง€์ˆ˜ ๋Œ€๋น„ ์ƒ๋Œ€์ ์œผ๋กœ ์ €์กฐํ•œ ์„ฑ๊ณผ๋ฅผ ๋‚ด์ง€๋งŒ, ํ•˜๋ฝ์žฅ์—์„œ๋Š” ๋” ์ž‘์€ ํญ์˜ ํ•˜๋ฝ์— ๊ทธ์น˜๋Š” ๊ฒฝํ–ฅ์ด ์žˆ์Œ์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค. ESG ๊ณต์‹œ๋Š” ์—…๊ณ„๋ฅผ ์„ ๋„ํ•˜๋Š” ์ˆ˜์ค€์ž…๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
9.65
๋ณ€๊ฒฝ
0
S&P 500 ์ง€์ˆ˜ ๋Œ€๋น„ ๋ฒ ํƒ€๊ฐ’
0.43
VaR
+2.20%
240์ผ ๊ธฐ์ค€ ์ตœ๋Œ€ ๋‚™ํญ
+21.36%
240์ผ ๊ธฐ์ค€ ๋ณ€๋™์„ฑ
+26.91%

๋Œ์•„๊ฐ€๊ธฐ

์ตœ๊ณ  ์ผ๊ฐ„ ์ˆ˜์ต๋ฅ 
60์ผ
+3.73%
120์ผ
+5.42%
5๋…„
+8.06%
์ตœ์ € ์ผ๊ฐ„ ์ˆ˜์ต๋ฅ 
60์ผ
-4.51%
120์ผ
-4.51%
5๋…„
-19.13%
์ƒคํ”„ ๋น„์œจ
60์ผ
-0.73
120์ผ
-0.10
5๋…„
+0.14

์œ„ํ—˜ ์š”์†Œ

์ตœ๋Œ€ ๋‚™ํญ
240์ผ
+21.36%
3๋…„
+26.62%
5๋…„
+34.88%
์ˆ˜์ต ๋Œ€๋น„ ๋‚™ํญ ๋น„์œจ
240์ผ
-0.47
3๋…„
-0.20
5๋…„
-0.08
์™œ๋„
240์ผ
-0.93
3๋…„
-2.44
5๋…„
-1.60

๋ณ€๋™์„ฑ

์‹คํ˜„ ๋ณ€๋™์„ฑ
240์ผ
+26.91%
5๋…„
+25.78%
ํ‘œ์ค€ํ™”๋œ ์ง„ํญ ๋ฒ”์œ„
240์ผ
+2.10%
5๋…„
+1.95%
ํ•˜๋ฐฉ ๋ฆฌ์Šคํฌ ์กฐ์ • ์ˆ˜์ต๋ฅ 
120์ผ
-16.81%
240์ผ
-16.81%
์ตœ๊ณ  ์ผ๊ฐ„ ์ƒ์Šน ๋ณ€๋™์„ฑ
60์ผ
+21.14%
์ตœ๊ณ  ์ผ๊ฐ„ ํ•˜๋ฝ ๋ณ€๋™์„ฑ
60์ผ
+21.86%

์œ ๋™์„ฑ

ํ‰๊ท  ํšŒ์ „์œจ
60์ผ
+0.18%
120์ผ
+0.20%
5๋…„
--
ํšŒ์ „์œจ ํŽธ์ฐจ
20์ผ
+6.70%
60์ผ
+2.42%
120์ผ
+15.16%

์œ ์‚ฌ ์ข…๋ชฉ
๎˜ฐ๎˜ฐ

์ œ์•ฝ
๎™
Sanofi SA
Sanofi SA
SNY
7.02 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
United Therapeutics Corp
United Therapeutics Corp
UTHR
8.88 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC
JAZZ
8.68 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc
LGND
8.59 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Kiniksa Pharmaceuticals International PLC
Kiniksa Pharmaceuticals International PLC
KNSA
8.45 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Royalty Pharma PLC
Royalty Pharma PLC
RPRX
8.41 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
๋” ๋ณด๊ธฐ
KeyAI
๎™